SCHEMBL6230016

SCHEMBL6230016

CS(=O)(=O)OCCCCCCCOc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.59
KDM4E B2RXH2 1/20 0.56
USP2 O75604 1/20 0.56
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56
MMP9 P14780 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
HDAC1 Q13547 3/20 0.53
HDAC2 Q92769 3/20 0.53
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HDAC9 Q9UKV0 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53
LTA4H P09960 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4741970 0.94 KCNA3 (0.56) KCNA3KDM4EUSP2ALDH1A1LMNA
SCHEMBL7976554 0.89 KCNA3 (0.52) KCNA3ALDH1A1LTA4HHTR1BMEN1
SCHEMBL10391332 0.84 KCNA3 (0.48) KCNA3KDM4EUSP2ALDH1A1LMNA
SCHEMBL3939161 0.84 PKM (0.47) KCNA3KDM4EALDH1A1HTR1BMEN1
SCHEMBL9714281 0.82 LTA4H (0.58) KCNA3LTA4HMEN1HTTKMT2A
SCHEMBL24041852 0.82 CA1 (0.51) KCNA3
SCHEMBL5482990 0.82 TP53 (0.67) TSHRHTT
Busulfan SCHEMBL16337522 0.80 KDM4E (0.65) KCNA3KDM4EUSP2ALDH1A1LMNA
SCHEMBL23014971 0.80 KDM4E (0.54) KDM4EUSP2ALDH1A1LMNAMMP9
SCHEMBL8435356 0.80 KDM4E (0.54) KDM4EUSP2ALDH1A1LMNAMMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063758-A1 INHIBITORS OF BACTERIAL NAD SYNTHETASE BROUILLETTE WAYNE J (US) 2004-04-01 US claimed
EP-1109805-B1 INHIBITORS OF BACTERIAL NAD SYNTHETASE UAB RESEARCH FOUNDATION (US) 2003-12-17 EP claimed
WO-2005002337-A1 DISINFECTANT COMPOSITIONS AND METHODS VIRTUAL DRUG DEVELOPMENT, INC. (US) 2005-01-13 WO disclosed
US-6727237-B2 Inhibitors of bacterial NAD synthetase BROUILLETTE WAYNE J (US) 2004-04-27 US disclosed
US-20040063758-A1 INHIBITORS OF BACTERIAL NAD SYNTHETASE BROUILLETTE WAYNE J (US) 2004-04-01 US disclosed
EP-1109805-B1 INHIBITORS OF BACTERIAL NAD SYNTHETASE UAB RESEARCH FOUNDATION (US) 2003-12-17 EP disclosed
US-6500852-B1 ENZYME INHIBITORS OF BACTERIAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) ENZYME LYASES USED AS BACTERICIDES, MICROBIOCIDE, ANTISEPTICS OR ANTIBIOTICS UNIVERSITY OF ALABAMA RESEARCH FOUNDATION 2002-12-31 US disclosed
EP-1109805-A1 INHIBITORS OF BACTERIAL NAD SYNTHETASE The UAB Research Foundation (US) 2001-06-27 EP disclosed
WO-2000010996-A1 INHIBITORS OF BACTERIAL NAD SYNTHETASE THE UAB RESEARCH FOUNDATION (US) 2000-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063758-A1 INHIBITORS OF BACTERIAL NAD SYNTHETASE COASY, NADK, NQO1 KCNA3 4748/4885KDM4E 2133/4885USP2 1901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.